Conventional vaccination campaign messages often miss their targets. A study in eight European countries shows that information on the benefits of vaccines can even reduce the willingness to get immunized. The researchers also looked into the factors that influenced the impact of messages, including low health literacy. A further study provides indications of the relationship between trust in vaccines and their approval procedures.
Current Covid-19 news
Current news from TUM about Covid-19 and the coronavirus Sars-CoV2: How we are researching solutions, informing the public and advising politics, supporting society with our own initiatives - and how we are keeping university operations running during this pandemic.
Deep learning algorithms to diagnose back pain, artificial enzymes for energy conversion facilities and a Covid-19 drug: the European Research Council (ERC) has announced funding for projects at the Technical University of Munich (TUM) in the form of two Consolidator Grants and one Proof of Concept Grant. The ERC Grants are among the most prestigious research awards in Europe.
A research team led by the Technical University of Munich (TUM) has successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus penetrates the cell. The findings could serve as the basis for a therapy to treat COVID-19.
The immune system develops a high-quality antibody response after three encounters with the coronavirus spike protein. These antibodies are also capable of neutralizing Omicron efficiently. This applies to people who are triple-vaccinated, to those having recovered and then received two vaccinations and to double-vaccinated individuals who have experienced a breakthrough infection. These are results of a study which tracked the antibodies of vaccinated and recovered individuals for two years.
rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of the drug. The team is using a substance that inhibits the inflammation-promoting microRNA. The therapy is expected to be efficacious in current and future mutations of SARS-CoV2.
At many places in the Technical University of Munich (TUM) research is being carried out on how to counteract the dangers posed by the SARS-CoV-2 virus. SAT.1 Bayern reported on December 27th and 28th in a two-part documentary about selected research projects.
The research neutron source Hein Maier-Leibnitz (FRM II) at the Technical University of Munich (TUM) is playing an important role in the investigation of mRNA nanoparticles similar to the ones used in the Covid-19 vaccines from vendors BioNTech and Pfizer. Researchers at the Heinz Maier-Leibnitz Zentrum (MLZ) used the high neutron flux available in Garching to characterize various formulations for the mRNA vaccine and thus to lay the groundwork for improving the vaccine's efficacy.
Despite myriad precautionary measures, virus-contaminated aerosols still pose a serious problem indoors. An invisible protective wall of UV-C light developed by researchers at the Technical University of Munich (TUM) and the Division of Infectious Diseases and Tropical Medicine at the LMU University Hospital Munich could provide a solution and reliably curb the spread of viruses and other pathogens in rooms in the future while allowing total freedom of movement.
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide collaboration. But medications against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell culture tests.
The Bavarian State Ministry of Science and Art is offering 500 vaccinationa against the corona virus without prior registration on Monday, December 13, starting at 10 am. The appointment, which is part of the Hi!A Festival for Art and Research in Bavaria, will take place at the Pinakothek der Moderne in the immediate vicinity of TUM's main campus.